Vemurafenib for BRAF V600-mutant Erdheim-Chester disease and Langerhans cell histiocytosis: analysis of data from the histology-independent, phase 2, open-label VE-BASKET study - Diamond, E L; Subbiah, V; Lockhart, A C (JAMA Oncol, 2018)
, et al.